Evidence map›Paper›PMID 26727365›Full record

ArticlePloS one2016

Efficacy of Dietary Lipid Control in Healing High-Fat and High-Cholesterol Diet-Induced Fibrotic Steatohepatitis in Rats.

Hazuki Tamada, Hisao Naito, Kazuya Kitamori, Yumi Hayashi, Nozomi Yamagishi, Masashi Kato, Tamie Nakajima

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Hazuki TamadaDepartment of Human Life and Environment, Kinjo Gakuin University, Nagoya, Japan.
Hisao NaitoDepartment of Public Health, Fujita Health University School of Medicine, Nagoya, Japan.
Kazuya KitamoriDepartment of Human Life and Environment, Kinjo Gakuin University, Nagoya, Japan.
Yumi HayashiDepartment of Pathophysiological Laboratory Sciences, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Nozomi YamagishiDepartment of Occupational and Environmental Health, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Masashi KatoDepartment of Occupational and Environmental Health, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Tamie NakajimaCollege of Life and Health Sciences, Chubu University, Kasugai, Japan.
Nagoya University · JPKinjo Gakuin University · JPChubu University · JPFujita Health University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nonalcoholic steatohepatitis is related to lifestyle, particularly to dietary habits. We developed diet-induced fibrotic steatohepatitis model stroke-prone spontaneously hypertensive 5/Dmcr (SHRSP5/Dmcr) rats showing steatosis, hepatic inflammation, and severe fibrosis induced by high-fat and -cholesterol (HFC) diet feeding. We aimed to clarify the efficacy of dietary intervention on the disease before and after the appearance of fibrosis. Male SHRSP5/Dmcr rats were divided into 9 groups; of these, 6 groups were fed control or HFC diet for several weeks and the remaining 3 groups represented the dietary intervention groups, which were fed the control diet after HFC diet feeding for 2 (before the appearance of fibrosis) or 8 (after the appearance of fibrosis) weeks. Dietary intervention before the appearance of fibrosis significantly improved the steatosis and reset the increased serum aspartate aminotransferase (AST), alanine aminotransferase (ALT), and serum total cholesterol (TC) levels. However, dietary intervention after the appearance of fibrosis was unable to reset the levels of hepatic TC, serum ALT, and fibrogenesis-related markers and had only a minor influence on hepatic fibrosis, although it reset the increased expression of transforming growth factor (TGF)-β1 and α-smooth muscle actin (SMA). It was noted that dietary intervention improved the increased AST levels; however, aggregated CD68-positive cells were still observed around the fibrosis area, which may be related to the findings of inflammatory cytokine mRNAs. Taken together, dietary intervention for fibrotic steatohepatitis improved steatosis, although it could not completely improve fibrosis.

Indexed as

Alanine TransaminaseAnimalsAntigens, CDAntigens, Differentiation, MyelomonocyticAspartate AminotransferasesBiomarkersBody WeightCD68 MoleculeCholesterol, DietaryCytokinesDietary FatsInflammation MediatorsLipidsMaleNon-alcoholic Fatty Liver DiseaseOrgan SizeAlanine TransaminaseAntigens, CDAntigens, Differentiation, MyelomonocyticAspartate AminotransferasesBiomarkersCD68 MoleculeCD68 protein, ratCholesterol, DietaryCytokinesDietary FatsInflammation MediatorsLipidsRNA, Messenger

Identifiers

PMID26727365
PMCPMC4699821
OpenAlexW2222795695

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.